G1 Therapeutics
(NASDAQ) GTHX
This security has been delisted. This page is retained for historical reference.
GTHX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowGTHX Financials
Key Financial Metrics (TTM)
Gross Margin
91%
Operating Margin
-48%
Net Income Margin
-58%
Return on Equity
-92%
Return on Capital
-43%
Return on Assets
-39%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$75.32M
Operating Income
$39.53M
EBITDA
$34.30M
Operating Cash Flow
$38.34M
Capital Expenditure
$0.00
Free Cash Flow
$38.34M
Cash & ST Invst.
$82.22M
Total Debt
$57.17M
G1 Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.55M
-61.0%
Gross Profit
$15.81M
-61.4%
Gross Margin
95.57%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
100
N/A
Net Income
$5.47M
-162.8%
EBITDA
$2.62M
-120.4%
Quarterly Fundamentals
Net Cash
$12.83M
-73.4%
Accounts Receivable
$13.31M
+1.0%
Inventory
$13.38M
-14.2%
Long Term Debt
$36.55M
-34.6%
Short Term Debt
$11.41M
N/A
Return on Assets
-39.47%
N/A
Return on Invested Capital
-43.05%
N/A
Free Cash Flow
$5.27M
-137.4%
Operating Cash Flow
$5.27M
-137.4%